BioSpace News Archive

GRI Bio, Inc. today announced that the Korean Intellectual Property Office (KIPO) has granted Patent No. 10-2665487 titled, “Prevention and Treatment of Inflammatory Conditions.”

Shineco Inc. announced today that on June 5, 2024, the Company received a formal notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).

Bluejay Diagnostics, Inc. today announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $8.75 million, before deducting underwriting discounts and other estimated expenses payable by the Company.

Paragonix Technologies, a leader in organ transplant technology, proudly announces the PancreasPak™ Organ Preservation System, the first FDA-cleared device designed to protect and monitor donor pancreases during transportation.

Form Bio, the provider of advanced computational life sciences technology and PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced a range of new initiatives aimed at advancing and unifying the AAV industry.

Meitheal Pharmaceuticals, Inc. (“Meitheal”) today announced it has gained exclusive commercial rights in the U.S. to YUSIMRY® (adalimumab-aqvh), a biosimilar of Humira® (adalimumab), through an exclusive license and supply agreement with its parent company, Hong Kong King-Friend Industry Co., Ltd. (“HKF”).

SGD Pharma, global leader in glass pharmaceutical packaging, has published its latest 2023 Corporate Social Responsibility (CSR) Report illustrating the sustainable practices deeply embedded in its business ethos.

Tubulis announced today that the U.S. Food and Drug Administration (“FDA”) has granted Fast Track designation to its lead antibody-drug conjugate (ADC) TUB-040 for the treatment of patients with platinum-resistant ovarian cancer.

As experts from around the globe gather at the annual Society for Informatics in Medicine conference, Bayer and Rad AI are announcing a collaboration to bring Rad AI’s cutting edge AI radiology operational solutions to Calantic ™ Digital Solution customers.

The National Eczema Association announced the second publication from its real-world research on eczema and its impacts on mental health.